QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.28B
Market cap8.28B
Price-Earnings ratio
19.24
Price-Earnings ratio19.24
Dividend yield
0.67%
Dividend yield0.67%
Average volume
1.77M
Average volume1.77M
High today
$40.46
High today$40.46
Low today
$39.67
Low today$39.67
Open price
$39.86
Open price$39.86
Volume
1.32M
Volume1.32M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$38.13
52 Week low$38.13

Stock Snapshot

The current QIAGEN(QGEN) stock price is $40.04, with a market capitalization of 8.28B. The stock trades at a price-to-earnings (P/E) ratio of 19.24 and offers a dividend yield of 66.9%.

As of 2026-03-31, QIAGEN(QGEN) stock has fluctuated between $39.67 and $40.46. The current price stands at $40.04, placing the stock +0.9% above today's low and -1.0% off the high.

The QIAGEN(QGEN)'s current trading volume is 1.32M, compared to an average daily volume of 1.77M.

During the past year, QIAGEN(QGEN) stock moved between $38.13 at its lowest and $57.82 at its peak.

During the past year, QIAGEN(QGEN) stock moved between $38.13 at its lowest and $57.82 at its peak.

QGEN News

Simply Wall St 2d
The Bull Case For Qiagen Could Change Following New QuantiFERON-TB Gold Plus Evidence - Learn Why

In March 2026, QIAGEN N.V. reported new clinical and health economic data showing its QuantiFERON-TB Gold Plus blood test improved tuberculosis infection detect...

The Bull Case For Qiagen Could Change Following New QuantiFERON-TB Gold Plus Evidence - Learn Why
Simply Wall St 4d
Qiagen Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection

Qiagen (QGEN) is back in focus after newly published clinical and health economic data supported its QuantiFERON-TB Gold Plus test for tuberculosis detection, t...

Qiagen Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection

Analyst ratings

61%

of 23 ratings
Buy
39.1%
Hold
60.9%
Sell
0%

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.